| Literature DB >> 25114794 |
Jai K Das1, Rehana A Salam1, Ahmed Arshad1, Hasina Maredia2, Zulfiqar A Bhutta3.
Abstract
In this paper, we aim to systematically analyze the effectiveness of community based interventions (CBI) for the prevention and control of non-helminthic diseases including dengue, trypanosomiasis, chagas, leishmaniasis, buruli ulcer, leprosy and trachoma. We systematically reviewed literature published up to May 2013 and included 62 studies in this review. Findings from our review suggest that CBI including insecticide spraying; insecticide treated bednets and curtains; community education and cleanliness campaigns; chemoprophylaxis through mass drug administration; and treatment have the potential to reduce the incidence and burden of non-helminthic diseases. Lack of data limited the subgroup analysis for integrated and non-integrated delivery strategies however, qualitative synthesis suggest that integrated delivery is more effective when compared to vertical interventions; however, such integration was possible only because of the existing vertical vector control programs. Community delivered interventions have the potential to achieve wider coverage and sustained community acceptance. Eradicating these diseases will require a multipronged approach including drug administration, health education, vector control and clean water and sanitation facilities. This would require high level governmental commitment along with strong partnerships among major stakeholders.Entities:
Keywords: Community based interventions; NTDs; Non-helminthic
Year: 2014 PMID: 25114794 PMCID: PMC4128610 DOI: 10.1186/2049-9957-3-24
Source DB: PubMed Journal: Infect Dis Poverty ISSN: 2049-9957 Impact factor: 4.520
Outcomes analyzed
| Chagas | Peri-domiciliary Infestation Rate |
| | Domiciliary Infestation Rate |
| | Chagas serology Rate |
| Dengue | Dengue Positive Serostatus |
| | House Index |
| | Mean Bretreau Index |
| | Ovitrap Index |
| Trachoma | Active Trachoma in All Age Groups |
| | Active Trachoma in Children |
| | Chlamydia Trachomatis Infection in All Age Groups |
| | Chlamydia Trachomatis Infection in Children |
| Leishmaniasis | Incidence of Cutaneous Leishmaniasis |
| | Incidence of Visceral Leishmaniasis |
| | Cure Rate for Cutaneous Leishmaniasis |
| Leprosy | Incidence of Leprosy |
| Leprosy Detection Rate |
Figure 1Search flow diagram.
Characteristics of included studies
| Gurtler 2009 | Pre-post | Argentina | Preventivelarvicides and insecticide spraying | General population | Non-integrated |
| Seng 2008 | Pre-post | Cambodia | Preventive guppies reared in household water tanks | General population | Non-integrated |
| Bang 1972 | Pre-post | Thailand | Preventive spraying | General population | Non-integrated |
| Kittayapong 2008 | Pre-post | Thailand | Preventive vector control | General population | Non-integrated |
| Madarieta 1999 | Pre-post | Philippines | Preventive Permethrin treated curtains | General population | Non-integrated |
| Nathan 1982 | Pre-post | West Indies | Preventive insecticide spraying | General population | Non-integrated |
| Neng 1987 | Pre-post | China | Preventive growing of Chinese cat fish to consume larvae | General population | Non-integrated |
| Pant 1971 | Pre-post | Bangkok | Preventive Malathion aerosols | General population | Non-integrated |
| Pai 2006 | Pre-post | Taiwan | Preventive cleanliness campaign | General population | Non-integrated |
| Nam 1997 | Pre-post | Vietnam | Preventive community education and cleanliness campaign | General population | Non-integrated |
| Umniyati 2000 | Pre-post | Indonesia | Preventive cleanliness campaign | General population | Non-integrated |
| Uribe 1984 | Pre-post | Columbia | Preventive aerosol applications of Malathion | General population | Non-integrated |
| Winch 2002 | Pre-post | Puerto Rico | Preventive community education program through televised public service announcements and posters | General population | Non-integrated |
| Kroeger 2006 | RCT | Mexico & Venezuela | Preventive insecticide treated curtains | General population | Non-integrated |
| Vanlerberghe 2009 | RCT | Cuba | Preventive insecticide treatments of household items | General population | Non-integrated |
| Espinoza-Gomez 2002 | RCT | Mexico | Preventive spraying and educational campaign | General population | Non-integrated |
| Lenhart 2008 | RCT | Haiti | Preventive insecticide treated bed nets | General population | Non-integrated |
| Arias 1999 | Pre-post | Paraguay | Preventivespraying, housing improvement, and a combination of spraying plus housing improvement | General population | Non-integrated |
| Ferro 1995 | Pre-post | Paraguay | Preventive insecticide spraying with lambdacyhalothrin | General population | Non-integrated |
| Gurtler 2007 | Pre-post | Argentina | Preventive community wide spraying with unspecified insecticide | General population | Non-integrated |
| Gurtler 2004 | RCT | Argentina | Preventiveinsecticide spraying | General population | Non-integrated |
| Alten 2002 | Pre-post | Turkey | Preventive Deltamethrin impregnated bed nets | General population | Non-integrated |
| Dietze 1997 | Pre-post | Brazil | Affected dogs were eliminated | General population | Non-integrated |
| Jalouk 2007 | Pre-post | Syria | Preventive ITNs vs. non-treated bed nets | General population | Non-integrated |
| Yaghoobi-Ershadi 2006 | Pre-post | Iran | ITNs, curtains and health education | General population | Non-integrated |
| Mohebali 2010 | Pre-post | Iran | Surveillance followed by treatment of detected cases | Children <12 years | PHC |
| Safi 2012 | Pre-post | Afghanistan | Thermotherapy for Cutaneous Leishmaniasis | General population | Non-integrated |
| Velasco-Casrejon 1997 | Pre-post | Mexico | Therapeutic localized current radio frequency ablation | General population | Non-integrated |
| Emami 2009 | RCT | Iran | ITNs | General population | Non-integrated |
| Gavgani 2002 | RCT | Iran | Community wide application of dog collars | Children | Non-integrated |
| Picado 2010 | RCT | India and Nepal | ITNs | General population | Non-integrated |
| Reyburn 2000 | RCT | Afghanistan | ITNs and Treated chaddars | General population | Non-integrated |
| Rojas 2006 | RCT | Columbia | Deltamethrin bed nets and health education | General population | Non-integrated |
| Namadi 2002 | Pre-post | Nigeria | Integration of services for leprosy detection and elimination through multi-drug therapy | General population | General health systems |
| Bakker 2005 | Pre-post | Indonesia | Preventive Rifampicin chemoprophylaxis | General population | Non-integrated |
| Rahim 2004 | Pre-post | Yemen | Leprosy control program through field searches for cases, clinics, referral centers | General population | Non-integrated |
| Schuring 2009 | Pre-post | Bangladesh | Chemoprophylaxis with Rifampicin and BCG | General population | Non-integrated |
| Cunha 2008 | RCT | Brazil | BCG revaccination of schoolchildren | 7-14 years old children | Non-integrated |
| Moet 2008 | RCT | Bangladesh | Rifampicin chemoprophylaxis for close contacts of cases | General population | Non-integrated |
| Hagan 2009 | Pre-post | Ghana | Treatment according to SAFE strategy with Azithromycin | General population | Non-integrated |
| Alemayehu 2007 | Pre-post | Ethiopia | Mass preventive treatment with Azithromycin | General population >1 years | Non-integrated |
| Astle 2006 | Pre-post | Zambia | Treatment of Trachoma through SAFE strategy | General population | Non-integrated |
| Atik 2006 | Pre-post | Vietnam | Treatment through SAFE, SA and S only strategy | Children aged 5–15 years | Non-integrated |
| Biebesheimer 2009 | Pre-post | Eithopia | Preventive annual or biannual mass distribution of azithromycin | General population | Non-integrated |
| Broman 2006 | Pre-post | Tanzania | Preventive mass treatment with azithromycin | General population | Non-integrated |
| Chidambaram 2006 | Pre-post | Ethiopia | Single mass preventive administration of Azithromycin | General population >1 years | Non-integrated |
| Ewald 2003 | Pre-post | Central Australia | Treatment according to SAFE strategy | Children <13 years of age and their households | Non-integrated |
| Gaynor 2003 | Pre-post | Nepal | Single treatment with Azithromycin | Children 1–10 years with their households | Non-integrated |
| Huguet 2009 | Pre-post | Cameroon | Mass preventive administration of Azithromycin drops | General population | Non-integrated |
| Khandekar 2006 | Pre-post | Vietnam | Preventive interventions including improved water andsanitation facilities and increased awareness about active trachoma in the community | General population | Non-integrated |
| Kumaresan 2003 | Pre-post | Multi-country | SAFE strategy | General population | Non-integrated |
| Lakew 2009 | Pre-post | Ethiopia | Mass preventive administration of oral azithromycin | General population | Non-integrated |
| Schemann 2007 | Pre-post | Mali | Mass community-based treatment of all residents, treatment of all children under 11 years of age and of women between 15 and 50 and treatment targeted to inhabitantsof households where at least one child had clinically active trachoma diagnosed with azithromycin | General population | Non-integrated |
| Edwards 2006 | RCT | Ethiopia | Radio messaging, IEC materials, and video van activities along with the SAFE strategy | General population | Non-integrated |
| Emerson 2004 | RCT | Gambia | Preventive intervention group that received regular insecticide spraying or provision of pit latrines (without additional health education) to each household | General population | Non-integrated |
| Abdou 2010 | RCT | Niger | Preventive building of clean water wells and health education | General population | Non-integrated |
| Fraser-Hurt 2001 | RCT | Gambia | Mass administration of Azithromycin vs Topical Tetracycline | General population | Non-integrated |
| Gebre 2011 | RCT | Ethiopia | Preventive mass annual versus twice-yearly azithromycin | General population | Non-integrated |
| House 2009 | RCT | Ethiopia | Preventive mass treatment four times per year vs. treatment delayed until after 1 year vs. routine annual mass administration of azithromycin | children aged between 1 and 10 years | Non-integrated |
| Melese 2008 | RCT | Ethiopia | Biannualvs. annual mass azithromycin administrations | General population | Non-integrated |
| Schacter 1999 | RCT | Egypt, Gambia and Tanzania | Community-wide oral azithromycin treatment or treatment with 1% topicaltetracycline | General population | Non-integrated |
| West 2007 | RCT | Tanzania | Mass treatment with topical tetracycline ointmentplus the face-washing programor treatment only | Children 1–7 years | Non-integrated |
Quality assessment of the included RCTs
| Gurtler 2004 | Done | Not computerized but done | Not clear | Done | Done | Not clear |
| Kroeger 2006 | Done | Not done | Done | Not done | Not clear | Yes |
| Vanlerberghe 2009 | Done | Not computerized but done | Not clear | Not clear | Not clear | Not clear |
| Espinoza-Gomez 2002 | Done | Not computerized but done | Not clear | Not clear | Not clear | No |
| Lenhart 2008 | Done | Not done | Done | Not clear | Not clear | Not clear |
| Edwards 2006 | Done | Not clear | Not clear | Not clear | Not clear | Not clear |
| Emerson 2004 | Done | Not clear | Not clear | Not clear | Done | No |
| Abdou 2010 | Done | Not clear | Not clear | Not clear | Not clear | Not clear |
| Fraser-Hurt 2001 | Done | Not clear | Not clear | Not clear | Not clear | Yes |
| Gebre 2011 | Done | Done | Done | Not clear | Done | Not clear |
| House 2009 | Done | Done | Done | Not clear | Done | Not clear |
| Melese 2008 | Done | Done | Done | Not clear | Done | No |
| Schacter 1999 | Done | Done | Not clear | Not clear | Not clear | Yes |
| West 2007 | Done | Not clear | Not clear | Not done | Done | No |
| Emami 2009 | Done | Done | Not clear | Not clear | Not clear | No |
| Gavgani 2002 | Done | Not done | Not clear | Not clear | Not clear | No |
| Picado 2010 | Done | Not clear | Not clear | Not clear | Not clear | Not clear |
| Reyburn 2000 | Done | Not clear | Not clear | Not clear | Done | No |
| Rojas 2006 | Done | Not clear | Not clear | Not clear | Done | Yes |
| Cunha 2008 | Done | Done | Done | Not done | Not done | Not clear |
| Moet 2008 | Done | Done | Done | Done | Done | No |
Results for overall and sub-group analysis according to type of study and treatment
| | |||||
|---|---|---|---|---|---|
| Peri-domiciliary Infestation Rate | 0.77 [0.53, 1.14] | 0.94 [0.67, 1.32] | 0.77 [0.53, 1.14] | No studies | |
| 8 datasets, 3 studies | 4 datasets, 1 study | 4 datasets, 2 studies | 8 datasets, 3 studies | ||
| Domiciliary Infestation Rate | No studies | No studies | |||
| 4 datasets, 2 studies | | 4 datasets, 2 studies | 4 datasets, 2 studies | ||
| Chagas Serology Rate (RR) | No studies | No studies | |||
| 4 datasets, 2 studies | 4 datasets, 2 studies | 4 datasets, 2 studies | |||
| House Index | No studies | No studies | |||
| 9 datasets, 9 studies | 9 datasets, 9 studies | 9 datasets, 9 studies | |||
| Ovitrap Index | No studies | No studies | |||
| 5 datasets, 3 studies | 5 datasets, 3 studies | 5 datasets, 3 studies | |||
| Mean Bretreau Index (SMD) | −0.04 [−0.28, 0.19] | −0.04 [−0.28, 0.19] | No studies | −0.04 [−0.28, 0.19] | No studies |
| 5 datasets, 2 studies | 5 datasets, 2 studies | 5 datasets, 2 studies | |||
| Dengue Positive Serostatus | 0.14 [0.01, 1.62] | No studies | |||
| 4 datasets, 4 studies | 2 datasets, 2 studies | 2 datasets, 2 studies | 4 datasets, 4 studies | ||
| Active Trachoma All Age Groups | |||||
| 6 datasets, 3 studies | 2 datasets, 1 study | 4 datasets, 2 studies | 2 datasets, 1 study | 4 datasets, 2 studies | |
| Active Trachoma in Children | |||||
| 20 datasets, 14 studies | 6 datasets, 4 studies | 14 datasets, 9 studies | 13 datasets, 8 studies | 7 datasets, 6 studies | |
| Chlamydia Trachomatic infection- All Age Groups | |||||
| 10 datasets, 6 studies | 5 datasets, 3 studies | 5 datasets, 3 studies | 7 datasets from 5 studies | 3 datasets, 1 studies | |
| Chlamydia Trachomatic infection in Children | No studies | ||||
| 9 datasets, 7 studies | 6 datasets, 4 studies | 3 datasets, 3 studies | 9 datasets, 7 studies | ||
| Incidence Cutaneous Leishmaniasis | No studies | ||||
| 9 datasets, 5 studies | 5 datasets, 3 studies | 4 datasets, 2 studies | 9 datasets, 5 studies | ||
| Incidence of Visceral Leishmaniasis | 0.93 [0.83, 1.04] | 0.97 [0.84, 1.12] | 0.87 [0.73, 1.04] | 0.93 [0.83, 1.04] | No studies |
| 4 datasets, 4 studies | 2 datasets, 2 studies | 2 datasets, 2 studies | 4 datasets, 4 studies | ||
| Cure Rate for Cutaneous Leishmaniasis (RR) | No studies | No studies | |||
| 2 datasets, 2 studies | 2 datasets, 2 studies | 2 datasets, 2 studies | |||
| Leprosy Incidence | No studies | ||||
| 8 datasets, 5 studies | 1 datasets, 1 studies | 7 datasets, 4 studies | 8 datasets, 5 studies | ||
| Leprosy detection rate | No studies | No studies | |||
| 2 datasets, 2 studies | 2 datasets, 2 studies | 2 datasets, 2 studies | |||
Estimates in bold represents statistical significance.
Figure 2Forest plot for the impact of CBI on dengue seropositive status.
Figure 3Forest plot for the impact of CBI on chagas domiciliairy infestation rate and serology. a and b.
Figure 4Forest plot for the impact of CBI on incidence of cutaneous leishmaniasis.
Figure 5Forest plot for the impact of CBI on incidence of leprosy.
Figure 6Forest plot for the impact of CBI on active trachoma (all ages).
Figure 7Summary of evidence suggesting areas of benefit according to disease.